View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
  1. News
July 22, 2014updated 01 Oct 2021 7:03am

UK and German hospitals adopt Oraya Therapy to treat wet AMD

UK-based Royal Hallamshire Hospital, part of the Sheffield Teaching Hospitals NHS Foundation Trust, and four university hospitals in Germany have adopted Oraya Therapeutics' therapy for the treatment of wet age-related macular degeneration (AMD).

By Pondari PremSai

OrayaTherapy_TreatmentRoom

UK-based Royal Hallamshire Hospital, part of the Sheffield Teaching Hospitals NHS Foundation Trust, and four university hospitals in Germany, have adopted Oraya Therapeutics’ therapy for the treatment of wet age-related macular degeneration (AMD).

The four German hospitals now offering Oraya Therapy are University Hospital Essen, University Hospital Schleswig-Holstein Campus Luebeck, University Hospital Freiburg, and the Medical Care Centre of the University Hospital of Cologne.

Several additional NHS hospitals and German hospitals are also expected to offer Oraya Therapy by the end of 2014.

Designed as a one-time, non-invasive treatment for wet AMD, Oraya Therapy has the potential to maintain or improve vision while reducing the required number of anti-vascular endothelial growth factor (anti-VEGF) injections into the eye.

"The adoption of Oraya Therapy at these five sites in the first half of 2014 represents a significant advance for Oraya, and we anticipate the second half of the year will meet or exceed this level of growth."

Oraya Therapeutics president and CEO Jim Taylor said: "The adoption of Oraya Therapy at these five sites in the first half of 2014 represents a significant advance for Oraya, and we anticipate the second half of the year will meet or exceed this level of growth.

"The reception to Oraya Therapy is very positive. An increasing number of patients and physicians are inquiring about this clinically proven and commercially tested therapeutic option.

"Importantly, these highly respected and centrally located treatment centres offer patients, their families and their physicians a valuable and much-needed option for treating wet AMD."

Oraya Therapy was first introduced in 2013 at VistaKlinik, located at Basel in Switzerland.

Oraya Therapy uses a low-voltage X-ray source with advanced robotics, a laser-guided positioning system, and a patented methodology for eye stabilisation and tracking.

The procedure takes about 20 minutes and requires no post-treatment recovery period before resuming normal activity.


Image: An Oraya Therapy treatment room. Photo: courtesy of Oraya Therapeutics, Inc.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Get important industry news and analysis sent to your inbox
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Hospital Management